Suzetrigine, to be sold under the brand name Journavx, is the first new type of pain medicine approved by the FDA in more ...
Fact checked by Nick Blackmer The Food and Drug Administration (FDA) on Thursday approved Journavx (suzetrigine), a new non-opioid painkiller that promises to be nonaddictive. Journavx is approved to ...
The drug, suzetrigine, made by Boston-based Vertex Pharmaceuticals and to be sold as Journavx, works only on nerves outside ...